Cerus (CERS) Total Non-Current Liabilities (2010 - 2026)
Cerus' (CERS) quarterly Total Non-Current Liabilities came in at $149.2 million in Q1 2026, up 1.84% year-on-year from $146.5 million in Q1 2025, and down 1.52% quarter-over-quarter from $151.5 million in Q4 2025.
Cerus (CERS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Cerus has disclosed Total Non-Current Liabilities across 17 years of filings, most recently posting $149.2 million for Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $149.2 million, up 1.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $149.2 million (up 1.84% YoY), and the FY2025 annual result was $151.5 million, up 8.11% from the prior year.
- Total Non-Current Liabilities came in at $149.2 million for Q1 2026 at Cerus, down from $151.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $154.0 million in Q3 2023 to a low of $131.5 million in Q3 2024.
- The 5-year median for Total Non-Current Liabilities is $144.4 million (2023), against an average of $143.1 million.
- Across the five-year window, Total Non-Current Liabilities decreased 14.63% in 2024 and rose 15.92% in 2025, its largest moves.
- Cerus' Total Non-Current Liabilities stood at $146.0 million in 2022, then retreated by 3.4% to $141.1 million in 2023, then dropped by 0.66% to $140.1 million in 2024, then increased by 8.11% to $151.5 million in 2025, then dropped by 1.52% to $149.2 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $149.2 million (Q1 2026), $151.5 million (Q4 2025), and $147.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 2.44 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 24.21 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 3.53 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 149.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149.20 Mn |
| Dec 31, 2025 | 151.50 Mn |
| Sep 30, 2025 | 147.76 Mn |
| Jun 30, 2025 | 152.53 Mn |
| Mar 31, 2025 | 146.51 Mn |
| Dec 31, 2024 | 140.13 Mn |
| Sep 30, 2024 | 131.46 Mn |
| Jun 30, 2024 | 131.58 Mn |
| Mar 31, 2024 | 135.54 Mn |
| Dec 31, 2023 | 141.07 Mn |
| Sep 30, 2023 | 153.99 Mn |
| Jun 30, 2023 | 144.37 Mn |
| Mar 31, 2023 | 147.36 Mn |
| Dec 31, 2022 | 146.03 Mn |
| Sep 30, 2022 | 138.08 Mn |
| Jun 30, 2022 | 136.57 Mn |
| Mar 31, 2022 | 138.22 Mn |
| Dec 31, 2021 | 149.54 Mn |
| Sep 30, 2021 | 135.47 Mn |
| Jun 30, 2021 | 136.82 Mn |